Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
GENE:
NUP98 (Nucleoporin 98 And 96 Precursor 2)
i
Other names:
NUP98, Nucleoporin 98 And 96 Precursor 2, Nuclear Pore Complex Protein Nup98-Nup96 2, Nucleoporin 98kDa, Nucleoporin 96, Nup98-Nup96, Nup98-96, NUP96, Nuclear Pore Complex Protein Nup98, GLFG-Repeat Containing Nucleoporin, NUP98/PHF23 Fusion 2 Protein, Nucleoporin 98kD, Nucleoporin 98, NUP196, ADIR2, ADAR2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4928
Related tests:
‹
AML Express™
FusionPlex™ Pan-Heme panel
AML Express™
FusionPlex™ Pan-Heme panel
›
Associations
(10)
News
Trials
VERI cancer hierarchy
Reset Filters
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
sorafenib
Sensitive: C3 – Early Trials
sorafenib
Sensitive
:
C3
NUP98 rearrangement
Acute Myelogenous Leukemia
NUP98 rearrangement
Acute Myelogenous Leukemia
venetoclax + revumenib
Sensitive: C3 – Early Trials
venetoclax + revumenib
Sensitive
:
C3
venetoclax + revumenib
Sensitive: C3 – Early Trials
venetoclax + revumenib
Sensitive
:
C3
NUP98-HOXD11 fusion + Chr t(2;11)(q31;p15)
Acute Myelogenous Leukemia
NUP98-HOXD11 fusion + Chr t(2;11)(q31;p15)
Acute Myelogenous Leukemia
Sensitive: C4 – Case Studies
Sensitive
:
C4
Sensitive: C4 – Case Studies
Sensitive
:
C4
NUP98-PRRX1 fusion
Acute Myelogenous Leukemia
NUP98-PRRX1 fusion
Acute Myelogenous Leukemia
cytarabine + idarubicin
Sensitive: C4 – Case Studies
cytarabine + idarubicin
Sensitive
:
C4
cytarabine + idarubicin
Sensitive: C4 – Case Studies
cytarabine + idarubicin
Sensitive
:
C4
NUP98-RARG fusion
Acute Myelogenous Leukemia
NUP98-RARG fusion
Acute Myelogenous Leukemia
arsenic trioxide
Sensitive: C4 – Case Studies
arsenic trioxide
Sensitive
:
C4
arsenic trioxide
Sensitive: C4 – Case Studies
arsenic trioxide
Sensitive
:
C4
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
mitoxantrone
Resistant: D – Preclinical
mitoxantrone
Resistant
:
D
mitoxantrone
Resistant: D – Preclinical
mitoxantrone
Resistant
:
D
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
NUP98-NSD1 fusion + FLT3-ITD mutation
Acute Myelogenous Leukemia
revumenib
Sensitive: D – Preclinical
revumenib
Sensitive
:
D
revumenib
Sensitive: D – Preclinical
revumenib
Sensitive
:
D
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
NUP98-NSD1 fusion
Acute Myelogenous Leukemia
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
VTP-50469
Sensitive: D – Preclinical
VTP-50469
Sensitive
:
D
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
NUP98-KDM5A fusion
Acute Myelogenous Leukemia
T-lymphocyte cell therapy
Sensitive: D – Preclinical
T-lymphocyte cell therapy
Sensitive
:
D
T-lymphocyte cell therapy
Sensitive: D – Preclinical
T-lymphocyte cell therapy
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.